Daniele Pastori | Ricerc@Sapienza

Pubblicazioni

Titolo	Pubblicato in	Anno
C2238 ANP gene variant promotes increased platelet aggregation through the activation of Nox2 and the reduction of cAMP	SCIENTIFIC REPORTS	2017
Carotid plaque detection improves the predictve value of CHA2DS2-VASc score in patients with non-valvular atrial fibrilation. the ARAPACIS study	INTERNATIONAL JOURNAL OF CARDIOLOGY	2017
Cardiovascular risk stratification in patients with non-valvular atrial fibrillation. the 2MACE score	INTERNAL AND EMERGENCY MEDICINE	2016
Validation of an LC-MS/MS method for the simultaneous quantification of dabigatran, rivaroxaban and apixaban in human plasma	BIOANALYSIS	2016
Pentraxin 3　- A Link Between Obesity, Inflammation and Vascular Disease?	CIRCULATION JOURNAL	2016
Antiphospholipid syndrome and anticoagulation quality: A clinical challenge	ATHEROSCLEROSIS	2016
Ankle-Brachial Index and cardiovascular events in atrial fibrillation. the ARAPACIS Study	THROMBOSIS AND HAEMOSTASIS	2016
Reply to. "inadequate anticoagulation by vitamin K antagonists and major adverse cardiovascular events other than stroke"	INTERNATIONAL JOURNAL OF CARDIOLOGY	2016
The role of nutraceuticals for the treatment of non-alcoholic fatty liver disease	BRITISH JOURNAL OF CLINICAL PHARMACOLOGY	2016
Short-term in vivo modifications of platelet NADPH oxidase 2 (NOX2) and prostaglandin F2α in HIV-1 patients on abacavir-based therapies	HIV MEDICINE	2016
Ridotta attività della lipasi acida lisosomiale: un possibile ruolo patogenetico nella nafld?	GIORNALE ITALIANO DELL'ARTERIOSCLEROSI	2016
Anti Xa oral anticoagulants inhibit in vivo platelet activation by modulating glycoprotein VI shedding	PHARMACOLOGICAL RESEARCH	2016
Low-grade endotoxemia, gut permeability and platelet activation in community-acquired pneumonia	JOURNAL OF INFECTION	2016
Impaired flow-mediated dilation in hospitalized patients with community-acquired pneumonia	EUROPEAN JOURNAL OF INTERNAL MEDICINE	2016
Reply to. "monitoring antivitamin K anticoagulants in antiphospholipid syndrome. a challenge in quality"	ATHEROSCLEROSIS	2016
Is there an interplay between adherence to mediterranean diet, antioxidant status, and vascular disease in atrial fibrillation patients?	ANTIOXIDANTS & REDOX SIGNALING	2016
Aging-Related Decline of Glutathione Peroxidase 3 and Risk of Cardiovascular Events in Patients With Atrial Fibrillation	JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE	2016
Age-related increase of thromboxane B2 and risk of cardiovascular disease in atrial fibrillation	ONCOTARGET	2016
Aspirin and renal insufficiency progression in patients with atrial fibrillation and chronic kidney disease	INTERNATIONAL JOURNAL OF CARDIOLOGY	2016
Atrial Fibrillation and Myocardial Infarction: A Systematic Review and Appraisal of Pathophysiologic Mechanisms	JOURNAL OF THE AMERICAN HEART ASSOCIATION. CARDIOVASCULAR AND CEREBROVASCULAR DISEASE	2016

« prima
< precedente
…
2
3
4
5
6
7
8
9
10
11
12
13
seguente ›
ultima »

ERC

LS4
LS4_10
LS7
LS7_10

Keywords

cardiovascular disease

anticoagulation

Novel oral anticoagulants

atrial fibrillation

atherosclerosis

NAFLD

NASH

antiphospholipid antibody syndrome

ischemic heart disease

cardiovascular risk

Thrombosis

Atherothrombosis

Progetti di Ricerca

Liver fibrosis and in-hospital outcomes in patients with acute coronary syndrome
Relationship between PCSK9 levels and major cardiovascular and cerebrovascular events (MACCE) in patients with non-alcoholic fatty liver disease (NAFLD): a prospective cohort study.